Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Succinate dehydrogenase complex assembly factor 1 (SDHAF1) is a small mitochondrial chaperone protein essential for the assembly and stability of succinate dehydrogenase (complex II), which plays a crucial role in both the TCA cycle and the mitochondrial electron transport chain[1][3][2]. SDHAF1 specifically facilitates the maturation of the iron-sulfur subunit (SDHB) of the SDH complex, protecting it from oxidative damage and enabling proper incorporation of iron-sulfur clusters by recruiting the iron-sulfur transfer complex (including HSC20 and ISCU)[1][2][3]. Mutations in the SDHAF1 gene have been associated with mitochondrial complex II deficiency and severe neurodegenerative disorders, most notably infantile leukoencephalopathy and, in rare cases, Leigh syndrome[1][4]. No known drugs directly target SDHAF1, but genetic testing for SDHAF1 mutations serves as a biomarker for certain mitochondrial diseases[1][3].
Not applicable (no current drugs directly target SDHAF1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinate dehydrogenase complex assembly factor 1 (SDHAF1).